Overview

Blue Light Emitting Diode Therapy on Vulvovaginal Candidiasis

Status:
Enrolling by invitation

Trial end date:
2023-05-01

Target enrollment:
0

Participant gender:
All

Summary

With the knowledge that VVC is an infectious disease of the genitourinary tract that is common in women of reproductive age, and because of the shortage of non-drug therapies for this condition, this study will aim to evaluate the effect of ultraviolet A/blue LED with a wavelength of 401 ± 5 nm in patients with a clinical manifestation of candidiasis and its ability to prevent recurrence.

Phase:

N/A

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Cairo University

Treatments:

Antifungal Agents
Clotrimazole
Miconazole

Criteria

Inclusion Criteria:

subject selection will be according to the following criteria:

1. Age will range between 18- 50 years.

2. All patients will be confirmed by culture and examination of fresh vaginal samples, to
have VVC.

3. All patients who will be enrolled to the study will have their informed consent.

Exclusion Criteria:

The participants will be excluded if they meet one of the following criteria:

1. Individuals on any other antifungal drugs.

2. Individuals with cardiopulmonary conditions.

3. Individuals undergoing another radiation therapy.

4. Sensory impairment